Resources

Treatment & Outcomes of Diabetes Patients During the COVID-19 Pandemic

After nearly six months of coping with the COVID-19 pandemic, InCrowd wanted to understand how diabetes patients and providers are managing their diseases and maintaining their treatment paradigms amidst the various challenges that threaten patient safety and access to care.

We would like to thank our friends at Market Cube for their help in sourcing this important research.

Methodology:

  • Method:
    • Physicians: 8-Minute MicroSurvey via InCrowd
    • Patients: 2-Minute MicroSurvey via InCrowd and Market Cube
  • Crowds:
    • US Primary Care Physicians (PCPs) and Endocrinologists (Endos)
    • Diabetes Patients
  • Sample Size:
    • Physicians: 102 Total
      • PCPs: 51%
      • Endos: 49%
    • Patients: 102 Total
  • Fielding Period:
    • Physicians: August 4, 2020 (3 hours)
    • Patients: August 5-7, 2020 (48 hours)
  • Screening Criteria
    • Physicians currently treating at least 15 diabetes type 1 patients and 25 type 2 patients
    • Patients actively seeking treatment for diabetes type 1 or type 2

InCrowd’s other COVID-19 Tracking Reports:

Please fill out the form below to access this content

Related Resources

IV Fluid Supply Chain Disruptions 

IV Fluid Supply Chain Disruptions 

Discover the Impact of Hurricane Helene on IV Fluid Availability When Hurricane Helene disrupted a key IV fluid manufacturing facility in the southeastern US, healthcare systems felt the ripple effects. InCrowd conducted research to uncover how this shortage has...

read more
Physician Burnout: Knowing Your Audience 

Physician Burnout: Knowing Your Audience 

Physician Engagement in a Time of Accelerated Professional Burnout  As burnout remains a significant challenge for healthcare professionals (HCPs), emerging research indicates a potential shift in this landscape. Our newest report unveils insights from a recent...

read more
ASH 2023 Post-Event Round-Up 

ASH 2023 Post-Event Round-Up 

Reactions and Insights from Hematologists and Hematology-Oncologists at ASH 2023  In December 2023, the American Society of Hematology (ASH) held its Annual Meeting, and InCrowd conducted a 1-minute MicroSurvey to gather insights from 100 US-based Hematologists and...

read more